Literature DB >> 23359259

The hedgehog pathway in breast cancer.

Sheikh Asim Ali1.   

Abstract

Entities:  

Year:  2012        PMID: 23359259      PMCID: PMC3551330          DOI: 10.3978/j.issn.1000-9604.2012.10.02

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


× No keyword cloud information.
  20 in total

1.  Hedgehog signaling pathway mediates the progression of non-invasive breast cancer to invasive breast cancer.

Authors:  Masae Souzaki; Makoto Kubo; Masaya Kai; Chizu Kameda; Haruo Tanaka; Tomoaki Taguchi; Masao Tanaka; Hideya Onishi; Mitsuo Katano
Journal:  Cancer Sci       Date:  2010-11-22       Impact factor: 6.716

2.  Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.

Authors:  Bhuvaneswari Ramaswamy; Yuanzhi Lu; Kun-Yu Teng; Gerard Nuovo; Xiaobai Li; Charles L Shapiro; Sarmila Majumder
Journal:  Cancer Res       Date:  2012-08-08       Impact factor: 12.701

3.  Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer.

Authors:  D Neil Watkins; David M Berman; Scott G Burkholder; Baolin Wang; Philip A Beachy; Stephen B Baylin
Journal:  Nature       Date:  2003-03-05       Impact factor: 49.962

Review 4.  Hedgehog signaling in mouse mammary gland development and neoplasia.

Authors:  M T Lewis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

Review 5.  Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis.

Authors:  Mohammad H Forouzanfar; Kyle J Foreman; Allyne M Delossantos; Rafael Lozano; Alan D Lopez; Christopher J L Murray; Mohsen Naghavi
Journal:  Lancet       Date:  2011-09-14       Impact factor: 79.321

6.  Expression and regulation mechanisms of Sonic Hedgehog in breast cancer.

Authors:  Wei Cui; Li-Hui Wang; Yuan-Yuan Wen; Min Song; Bai-Lin Li; Xiao-Ling Chen; Man Xu; Su-Xiang An; Jing Zhao; Yi-Yan Lu; Xiao-Yi Mi; En-Hua Wang
Journal:  Cancer Sci       Date:  2010-01-15       Impact factor: 6.716

7.  Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

Authors:  Aleksandar Sekulic; Michael R Migden; Anthony E Oro; Luc Dirix; Karl D Lewis; John D Hainsworth; James A Solomon; Simon Yoo; Sarah T Arron; Philip A Friedlander; Ellen Marmur; Charles M Rudin; Anne Lynn S Chang; Jennifer A Low; Howard M Mackey; Robert L Yauch; Richard A Graham; Josina C Reddy; Axel Hauschild
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245

8.  Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation.

Authors:  Shuntaro Nagai; Masafumi Nakamura; Kosuke Yanai; Junji Wada; Takashi Akiyoshi; Hiroshi Nakashima; Kenoki Ohuchida; Norihiro Sato; Masao Tanaka; Mitsuo Katano
Journal:  Cancer Sci       Date:  2008-04-11       Impact factor: 6.716

9.  Study on the skip metastasis of axillary lymph nodes in breast cancer and their relation with Gli1 expression.

Authors:  Huan Wang; Xiao-Yun Mao; Ting-Ting Zhao; Xin-Yu Zheng; Feng Jin; Ji-Guang Li
Journal:  Tumour Biol       Date:  2012-07-14

10.  Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1.

Authors:  M T Lewis; S Ross; P A Strickland; C W Sugnet; E Jimenez; M P Scott; C W Daniel
Journal:  Development       Date:  1999-11       Impact factor: 6.868

View more
  3 in total

Review 1.  Hedgehog Autoprocessing: From Structural Mechanisms to Drug Discovery.

Authors:  Nabin Kandel; Chunyu Wang
Journal:  Front Mol Biosci       Date:  2022-05-20

2.  QM-FISH analysis of the genes involved in the G1/S checkpoint signaling pathway in triple-negative breast cancer.

Authors:  Sheng Zhang; Yingbo Shao; Guofang Hou; Jingchao Bai; Weiping Yuan; Linping Hu; Tao Cheng; Anders Zetterberg; Jin Zhang
Journal:  Tumour Biol       Date:  2013-10-05

3.  The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells.

Authors:  Feng Chai; Jiangang Zhou; Cheng Chen; Song Xie; Xiao Chen; Ping Su; Jun Shi
Journal:  Onco Targets Ther       Date:  2013-11-12       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.